These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 6997189)

  • 1. Effect of gram-negative bacterial lipopolysaccharide-derived polysaccharides, glycolipids, and lipopolysaccharides on rabbit and human platelets in vitro.
    Abdelnoor AM; Kassem H; Bikhazi AB; Nowotny A
    Immunobiology; 1980 Jul; 157(2):145-53. PubMed ID: 6997189
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Platelet-endotoxin interaction: a review.
    Semeraro N; Fumarola D; Telesforo P; Vermylen J
    Boll Ist Sieroter Milan; 1976; 55(6):577-86. PubMed ID: 798597
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The role of thromboxane A2 in endotoxin-induced aggregation of guinea-pig platelets in vitro.
    Bult H; Herman AG
    Agents Actions Suppl; 1979; (4):147-55. PubMed ID: 386740
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Effects of E. coli LPS on human platelet aggregation].
    Baba K
    Masui; 1994 Mar; 43(3):339-45. PubMed ID: 8182878
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mechanisms of lipopolysaccharide-initiated rabbit platelet responses. II. Evidence that lipid A is responsible for binding of lipopolysaccharide to the platelet.
    Morrison DC; Oades ZG
    J Immunol; 1979 Mar; 122(3):753-8. PubMed ID: 448073
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lipopolysaccharide treatment reduces rat platelet aggregation independent of intracellular reactive-oxygen species generation.
    Lopes-Pires ME; Casarin AL; Pereira-Cunha FG; Lorand-Metze I; Antunes E; Marcondes S
    Platelets; 2012; 23(3):195-201. PubMed ID: 21806496
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Platelet aggregation and stimulation of leucocyte procoagulant activity by rickettsial lipopolysaccharides in rabbits and in man.
    Miragliotta G; Fumarola D; Colucci M; Semeraro N
    Experientia; 1981 Jan; 37(1):47-9. PubMed ID: 6781928
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interactions of the classical and alternate complement pathway with endotoxin lipopolysaccharide. Effect on platelets and blood coagulation.
    Kane MA; May JE; Frank MM
    J Clin Invest; 1973 Feb; 52(2):370-6. PubMed ID: 4683877
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of tetanus toxin, Salmonella typhimurium porin, and bacterial lipopolysaccharide on platelet aggregation.
    Matera C; Falzarano C; Berrino L; Rossi F
    J Med; 1992; 23(5):327-38. PubMed ID: 1335019
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Endotoxin receptor site. II. Specificity of endotoxin receptor of platelets and sensitivity to endotoxin in vivo.
    Washida S
    Acta Med Okayama; 1978 Jul; 32(3):217-23. PubMed ID: 151487
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mechanisms underlying the inhibitory effects of lipopolysaccharide on human platelet adhesion.
    Morganti RP; Cardoso MH; Pereira FG; Lorand-Metze I; De Nucci G; Marcondes S; Antunes E
    Platelets; 2010; 21(4):260-9. PubMed ID: 20218907
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of some bacterial products on platelet electrophoretic mobility (PEM).
    Fumarola D; Jirillo E; Monno R; Munno I; De Santis A
    Boll Ist Sieroter Milan; 1977 Sep; 56(4):391-6. PubMed ID: 410424
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Studies on pyrogenic tolerance to bacterial lipopolysaccharide in rabbits.
    Kanoh S; Nishio A; Kawasaki H
    Biken J; 1977 Jun; 20(2):69-75. PubMed ID: 337968
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Anti-thrombotic effects and bleeding risk of AJvW-2, a monoclonal antibody against human von Willebrand factor.
    Kageyama S; Yamamoto H; Nagano M; Arisaka H; Kayahara T; Yoshimoto R
    Br J Pharmacol; 1997 Sep; 122(1):165-71. PubMed ID: 9298543
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Aggregation, release and desensitization induced in platelets from five species by platelet activating factor (PAF).
    Cargill DI; Cohen DS; Van Valen RG; Klimek JJ; Levin RP
    Thromb Haemost; 1983 Jun; 49(3):204-7. PubMed ID: 6879508
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mediation systems in bacterial lipopolysaccharide-induced hypotension and disseminated intravascular coagulation. I. The role of complement.
    Ulevitch RJ; Cochrane CG; Henson PM; Morrison DC; Doe WF
    J Exp Med; 1975 Dec; 142(6):1570-90. PubMed ID: 1104750
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunocycte stimulation in vitro by nontoxic bacterial lipopolysaccharide derivatives.
    Frank S; Specter S; Nowotny A; Friedman H
    J Immunol; 1977 Sep; 119(3):855-60. PubMed ID: 330757
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lipid A, the active part of bacterial endotoxins in inducing serum colony stimulating activity and proliferation of splenic granulocyte/macrophage progenitor cells.
    Apte RN; Galanos C; Pluznik DH
    J Cell Physiol; 1976 Jan; 87(1):71-8. PubMed ID: 1081990
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Human platelets aggregate during antigen-antibody reactions at different antigen-antibody ratios.
    Battersby B; Sherwood T; Winocour P; Virella G
    J Clin Lab Immunol; 1984 Oct; 15(2):57-61. PubMed ID: 6520859
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Critical aggregation concentrations of gram-negative bacterial lipopolysaccharides (LPS).
    Aurell CA; Wistrom AO
    Biochem Biophys Res Commun; 1998 Dec; 253(1):119-23. PubMed ID: 9875230
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.